Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
Crossref DOI link: https://doi.org/10.1007/s10067-016-3474-8
Published Online: 2016-11-10
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hosoya, Tatsuo
Sasaki, Tomomitsu
Ohashi, Tetsuo
License valid from 2016-11-10